Drug Therapy
Article
Evidence-based tools for premenstrual disorders
A symptoms chart, an algorithm, and a treatment options resource are among the tools you’ll find here to diagnose and treat premenstrual symptoms...
FDA/CDC
FDA approves fidaxomicin for treatment of C. difficile–associated diarrhea in kids
Approval was based on results from SUNSHINE, a phase 3, multicenter, investigator-blind, randomized, parallel-group study in 142 pediatric...
FDA/CDC
New Vascepa indication opens up treatment to millions; “Most significant event since statins”
Conference Coverage
Cardiac biomarkers refine antihypertensive drug initiation decisions
PHILADELPHIA – Analysis showcases a better way to select patients for intensive BP lowering.
News
Value analysis of JAK inhibitors for RA hampered by limited data
Janus kinase (JAK) inhibitors may provide a net health benefit, but their long-term economic value is unclear, according to a report by the...
Conference Coverage
Are providers asking about menstrual bleeding before/during anticoagulant therapy?
News
Medicaid spending on MS drugs rose despite introduction of generic glatiramer
“Although some of this increase is attributable to the 2014 Medicaid expansion, the primary driver was rising DMT costs per prescription, which...
News
FDA committee rejects oxycodegol, new opioid designed for less abuse
A novel opioid molecule designed to have less abuse potential with slower CNS entry received a unanimous FDA committee turn down.
FDA/CDC
FDA warns of possible cancer risk with lorcaserin
Results from a clinical trial assessing the drug’s safety showed the possible risk increase.
News
Expedited review programs not shortening drug development
While it may be hard to understand the impact of the many expedited review programs introduced at the FDA, there is still room for improvement in...